We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Argent Biopharma Limited 30 July 2024 30 July 2024 Argent BioPharma Ltd. (Argent BioPharma or the Company) June 2024 Quarter Activity Report and Cash Flow Statement Argent...
The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by A ...
Argent Biopharma Limited 16 July 2024 16 July 2024 Argent BioPharma Ltd. (Argent BioPharma or the Company) Placing to Raise US$2,000,000 Argent BioPharma, an innovative...
Argent Biopharma Limited 01 July 2024 1 July 2024 Argent BioPharma Ltd. (Argent BioPharma or the Company) Company Presentation Argent BioPharma, an innovative multidisciplinary drug...
Argent Biopharma Limited 01 July 2024 1 July 2024 Argent BioPharma Ltd. (Argent BioPharma or the Company) Placing to Raise US$500,000 Argent BioPharma, an innovative...
Argent Biopharma Limited 21 June 2024 21 June 2024 Argent BioPharma Ltd. (Argent BioPharma or the Company) Appointment of UK Corporate Broker Argent BioPharma, an innovative...
Argent Biopharma Limited 23 May 2024 23 May 2024 Argent BioPharma Ltd. Change of OTCQB Company Code Argent BioPharma Ltd. (Argent BioPharma or the Company) advises that as of 20 May...
Argent BioPharma Ltd on Tuesday celebrated the approval of its shares to trading in the US, and also announced the ap ...
Argent Biopharma Limited 07 May 2024 7 May 2024 Argent BioPharma Ltd. Argent BioPharma Commences Trading on the OTCQB Venture Market and Appoints CFO Argent BioPharma Ltd. (Argent...
Argent Biopharma Limited 30 April 2024 30 April 2024 Argent BioPharma Ltd PDMR Notification Argent BioPharma Ltd (Argent BioPharma, RGT or the Company), wishes to advise that the...
| Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | IX |
| 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | IX |
| 12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | IX |
| 26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | IX |
| 52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | IX |
| 156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | IX |
| 260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | IX |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
